Graphene oxide toxicity in osteosarcoma

Researchers from the University of Alberta, Canada, discuss their osteosarcoma research. Dr. David Eisenstat introduces osteosarcoma, Dr. Fan Shen covers IGF metabolism, and Dr. Consolato Sergi talks about IGFBP3. Dr. Mervin Lee Burnett elaborates on graphene oxide toxicity in IGF and IGFBP3 CRISPR knockout osteosarcoma cells.

Related Resources
Cited Publications Database: https://www.synthego.com/publications
Featured Researchers: https://www.synthego.com/customers
----
Learn More About Synthego: https://www.synthego.com
Subscribe Now to The Bench Blog: https://www.synthego.com/blog
Schedule a Free CRISPR Assessment: https://www.synthego.com/discovery

SYNTHEGO ON SOCIAL
https://www.twitter.com/Synthego
https://www.linkedin.com/company/synt...
https://www.facebook.com/Synthego

ABOUT SYNTHEGO
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.

The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs.

By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology.

#CRISPRResearch

Видео Graphene oxide toxicity in osteosarcoma канала Synthego